These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15139558

  • 1. Hypercoagulability and venous thromboembolism: a review.
    Mazza JJ.
    WMJ; 2004; 103(2):41-9. PubMed ID: 15139558
    [Abstract] [Full Text] [Related]

  • 2. Thromboembolism in women.
    Martinelli I.
    Semin Thromb Hemost; 2006 Oct; 32(7):709-15. PubMed ID: 17024598
    [Abstract] [Full Text] [Related]

  • 3. Inherited thrombophilia and venous thromboembolism.
    Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C, Prandoni P.
    Semin Thromb Hemost; 2006 Oct; 32(7):700-8. PubMed ID: 17024597
    [Abstract] [Full Text] [Related]

  • 4. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J, Gompel A.
    Rev Prat; 2007 Apr 15; 57(7):759-66. PubMed ID: 17626321
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Venous thromboembolism: risk factors for recurrence.
    Zhu T, Martinez I, Emmerich J.
    Arterioscler Thromb Vasc Biol; 2009 Mar 15; 29(3):298-310. PubMed ID: 19228602
    [Abstract] [Full Text] [Related]

  • 12. [Antiphospholipid syndrome and venous thromboembolism: the role of congenital thrombophilia].
    Poli D, Gensini GF.
    Ann Ital Med Int; 2005 Mar 15; 20(4):218-23. PubMed ID: 16610253
    [Abstract] [Full Text] [Related]

  • 13. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB, Warfarin Optimal Duration Italian Trial (WODIT) Investigators.
    Thromb Res; 2005 Mar 15; 116(4):301-6. PubMed ID: 16038714
    [Abstract] [Full Text] [Related]

  • 14. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen and Thromboembolism Risk (ESTHER) Study Group.
    Circulation; 2005 Nov 29; 112(22):3495-500. PubMed ID: 16301339
    [Abstract] [Full Text] [Related]

  • 15. [Prevention of venous thromboembolism in paediatry].
    Blatný J.
    Vnitr Lek; 2006 Mar 29; 52 Suppl 1():68-72. PubMed ID: 16637453
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thrombophilia screening: a matter of debate.
    Kamphuisen PW, Rosendaal FR.
    Neth J Med; 2004 Jun 29; 62(6):180-7. PubMed ID: 15460496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.